United Therapeutics Corporation
1110 Spring Street
Silver Spring
Maryland
20910
United States
Tel: 301-608-9292
Fax: 301-608-9291
Website: http://www.unither.com/
351 articles with United Therapeutics Corporation
-
New research indicates the heart that David Bennet received was infected with porcine cytomegalovirus, a virus that can cause respiratory and pregnancy complications in pigs.
-
United Therapeutics Corporation Reports First Quarter 2022 Financial Results
5/4/2022
United Therapeutics Corporation, a public benefit corporation, announced its financial results for the quarter ended March 31, 2022.
-
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the 2022 American Thoracic Society International Conference
4/29/2022
United Therapeutics Corporation announced that eight posters and three mini-symposia across the company’s commercial and development portfolio will be presented at the 2022 American Thoracic Society International Conference, taking place May 13-18, 2022, in San Francisco.
-
United Therapeutics Announces the Publication of Tyvaso DPI™ BREEZE Clinical and Long-term Data in the Journal Pulmonary Circulation
4/6/2022
United Therapeutics Corporation, a public benefit corporation, announced the publication of additional clinical and long-term safety data from the BREEZE study evaluating Tyvaso DPI™ in patients with pulmonary arterial hypertension in the journal Pulmonary Circulation.
-
United Therapeutics Corporation to Present at the Oppenheimer 32nd Annual Healthcare Conference
3/8/2022
United Therapeutics Corporation announced that James Edgemond, Chief Financial Officer and Treasurer, will provide an overview and update on the company’s business during a fireside chat session at the Oppenheimer 32nd Annual Healthcare Conference.
-
United Therapeutics Corporation to Present at the Cowen 42nd Annual Health Care Conference
3/1/2022
The session will take place virtually on Tuesday, March 8, 2022, from 11:10 a.m. to 11:40 a.m., Eastern Standard Time, and can be accessed via a live webcast on the United Therapeutics website at https://ir.unither.com/events-and-presentations.
-
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results
2/24/2022
United Therapeutics Corporation, a public benefit corporation, announced its financial results for the fourth quarter and year ended December 31, 2021.
-
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2021 Financial Results Before the Market Opens on Thursday, February 24, 2022
2/21/2022
United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its fourth quarter and full year 2021 financial results before the market opens on Thursday, February 24, 2022.
-
United Therapeutics Corporation Announces Historic Achievements in its Xenotransplantation Programs
1/21/2022
United Therapeutics Corporation, a public benefit corporation with a purpose to provide a brighter future for patients, announced that the world's first recipient of an investigational genetically-modified xenotransplanted organ, UT’s UHeart™, reached a two-week milestone.
-
Xenotransplantation company United Therapeutics Corporation is making significant headway in using genetically modified animal organs as a replacement for failing organs in humans.
-
United Therapeutics Corporation to Webcast Executive Fireside Chat Conversation With J.P. Morgan Analyst
12/30/2021
United Therapeutics Corporation announced that Martine Rothblatt, Ph.D., Chairperson and Chief Executive Officer, and Michael Benkowitz, President and Chief Operating Officer of United Therapeutics, will provide an overview and update on the company’s business during a fireside chat conversation hosted by J.P. Morgan biotechnology analyst Jessica Fye.
-
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2022
12/3/2021
United Therapeutics (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today announced that the company has been named on Newsweek’s list of America’s Most Responsible Companies 2022.
-
United Therapeutics Corporation Reports Third Quarter 2021 Financial Results
11/3/2021
United Therapeutics CorporationUnited Therapeutics Corporation, a public benefit corporation with a purpose to provide a brighter future for patients, announced its financial results for the quarter ended September 30, 2021.
-
United Therapeutics Corporation To Present At The Credit Suisse 30th Annual Healthcare Conference
11/1/2021
United Therapeutics Corporation announced that Michael Benkowitz, President and Chief Operating Officer of United Therapeutics, will provide an overview and update on the company's business during a fireside chat session at the Credit Suisse 30th Annual Healthcare Conference.
-
United Therapeutics Corporation To Report Third Quarter 2021 Financial Results Before The Market Opens On Wednesday, November 3, 2021
10/27/2021
United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2021 financial results before the market opens on Wednesday, November 3, 2021 .
-
United Therapeutics Details New Data Presented at CHEST Annual Meeting 2021
10/21/2021
United Therapeutics Corporation, a public benefit corporation with a purpose to provide a brighter future for patients, detailed the new clinical and real-world evidence on pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease presented at CHEST 2021, the annual meeting of the American College of Chest Physicians.
-
United Therapeutics Provides an Update on the Progress of the Tyvaso DPI™ New Drug Application
10/18/2021
United Therapeutics Corporation announced an update on the U.S. Food and Drug Administration review of the new drug application for Tyvaso DPI™, for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease, to improve exercise capacity.
-
United Therapeutics to Present New Data at CHEST Annual Meeting 2021
10/11/2021
United Therapeutics Corporation, a public benefit corporation with a purpose to provide a brighter future for patients, announced new data on pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease will be presented as posters at CHEST 2021, the annual meeting of the American College of Chest Physicians, which will be held virtually October 17-20.
-
United Therapeutics Releases its Annual Corporate Responsibility Report
9/10/2021
United Therapeutics Corporation (Nasdaq: UTHR) today announced the release of its second annual Corporate Responsibility Report with 2020 highlights
-
United Therapeutics Presents Tyvaso DPI™ BREEZE Clinical Data At The European Respiratory Society International Congress 2021
9/7/2021
United Therapeutics Corporation presented new clinical data from the BREEZE study evaluating Tyvaso DPI™ in patients with pulmonary arterial hypertension at the European Respiratory Society International Congress 2021.